Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Matsumotokiyoshi Holdings Co ( (JP:3088) ) has shared an update.
MatsukiyoCocokara & Co. reported consolidated net sales of ¥839.3 billion for the nine months ended December 31, 2025, up 4.7% year on year, with operating profit rising 4.2% to ¥64.25 billion and profit attributable to owners of the parent advancing 3.3% to ¥42.59 billion. The company’s equity ratio remained strong at 71.9% and net assets per share increased, while basic earnings per share climbed to ¥106.79, reflecting steady profitability and a solid balance sheet.
The retailer maintained its dividend policy, having already paid a higher interim dividend of ¥24 per share for the current fiscal year and forecasting a full-year dividend of ¥48, up from ¥44 in the prior year. It also left its full-year earnings forecast unchanged, projecting net sales of ¥1.1 trillion and a 3.3% increase in full-year profit, signaling confidence in sustained but moderate growth and income stability for shareholders.
The most recent analyst rating on (JP:3088) stock is a Hold with a Yen3200.00 price target. To see the full list of analyst forecasts on Matsumotokiyoshi Holdings Co stock, see the JP:3088 Stock Forecast page.
More about Matsumotokiyoshi Holdings Co
MatsukiyoCocokara & Co. is a Japan-based retail group operating drugstores and health and beauty outlets, focused on pharmaceuticals, daily necessities and personal care products. Listed on the Tokyo Stock Exchange under code 3088, the company targets domestic consumers with a broad health, wellness and lifestyle offering across its nationwide store network.
Average Trading Volume: 1,641,127
Current Market Cap: Yen1060.9B
For an in-depth examination of 3088 stock, go to TipRanks’ Overview page.